Differential Diagnosis of a Female Patient with Dysuria and Abdominal Pain

A female patient presents with dysuria and abdominal pain, but a negative urine culture and lack of response to trimethoprim suggest an alternative diagnosis to urinary tract infection. Here are some possible differential diagnoses:

Chlamydia trachomatis: This sexually transmitted micro-organism can cause cervicitis, salpingitis, endometritis, and urethritis. Many carriers are asymptomatic, but nucleic acid amplification can diagnose the infection from a urine sample, endocervical or vulvovaginal swab.

Trichomonas vaginalis: This protozoan causes trichomoniasis, a sexually transmitted infection that commonly presents with abnormal vaginal discharge, odour, itching, burning, soreness, and dyspareunia. Abdominal pain and dysuria are not typical symptoms.

Escherichia coli: This bacterium is the most common cause of uncomplicated UTIs, but negative urine cultures and trimethoprim resistance suggest an alternative diagnosis.

Candida albicans: This fungus can cause vulvovaginal thrush, which may present with dysuria and vulval pruritus, but not abdominal pain. A high vaginal swab can diagnose the infection.

Bacterial vaginosis: This overgrowth of bacteria in the vagina affects vaginal pH and causes a fishy smelling discharge, but not abdominal pain or dysuria. A high vaginal swab can diagnose the condition.

Differential diagnosis of diarrhoea in an HIV-positive patient

Human cryptosporidiosis, caused by Cryptosporidium species, is a common opportunistic infection in HIV/AIDS patients, leading to prolonged and severe diarrhoea. Escherichia coli can cause urinary and enteric infections, but an alternative aetiology is more likely in this case. Staphylococcus aureus is a commensal bacterium that can cause various infections, but it is not suggested by this clinical scenario. Entamoeba histolytica, which causes amoebiasis, is more prevalent in developing countries and may cause dysentery and invasive extra-intestinal manifestations, but an alternative aetiology is more likely in this case. Salmonella species can be transmitted orally via contaminated food or beverages and may cause non-typhoidal enterocolitis, focal disease, or typhoid fever, but an alternative aetiology is more likely in this case, given the severity of diarrhoea and the patient’s HIV-positive status. Therefore, a thorough differential diagnosis is necessary to identify the underlying cause of diarrhoea in this patient and provide appropriate treatment.

Antibiotics for Dog Bite Infections: Recommended and Not Recommended Options

Dog bites can lead to infections caused by various micro-organisms, including anaerobic mouth flora and bacteria. Co-amoxiclav, a combination of amoxicillin and clavulanic acid, is the recommended antibiotic for dog bite-related infections, as it is effective against the most likely organisms. Fluconazole, an antifungal agent, is not indicated for such infections, as fungal micro-organisms in dogs usually cause only superficial skin rashes. Metronidazole, although effective against anaerobic bacteria, is not recommended for dog bite-related infections, except for patients allergic to penicillin. Aciclovir is not used for dog bite-related infections, as it is restricted to treating varicella-zoster and herpes zoster. Flucloxacillin, although recommended for skin infections, is not active against anaerobic bacteria and is not recommended for dog bite-related infections.

Antiretroviral therapy (ART) for HIV involves a combination of at least three drugs, typically two nucleoside reverse transcriptase inhibitors (NRTI) and either a protease inhibitor (PI) or a non-nucleoside reverse transcriptase inhibitor (NNRTI). Entry inhibitors, NRTIs, NNRTIs, PIs, and integrase inhibitors are all used to manage HIV. The 2015 BHIVA guidelines recommend starting ART as soon as a patient is diagnosed with HIV. Each drug has its own side effects, and some of the common ones include peripheral neuropathy, renal impairment, osteoporosis, diabetes, hyperlipidemia, and P450 enzyme interaction.

Common Antibiotics and Antifungals: Uses and Dosages

Metronidazole, Azithromycin, Co-amoxiclav, Fluconazole, and Nystatin are common antibiotics and antifungals used to treat various infections. Metronidazole is recommended for bacterial vaginosis and can be taken orally or applied topically. Azithromycin is used for Chlamydia, gonorrhea, and chancroid. Co-amoxiclav is a broad-spectrum antibiotic used for respiratory and urinary tract infections, among others. Fluconazole is an oral antifungal used for severe oral and vaginal candidiasis. Nystatin is an antifungal used for oral candidiasis. Dosages and treatment durations vary depending on the specific infection being treated.

Chancroid is the culprit behind painful genital ulcers that have a ragged border and are accompanied by tender inguinal lymphadenopathy. Haemophilus ducreyi is the organism responsible for causing chancroid. While herpes simplex virus can also cause painful genital ulcers, they tend to be smaller and multiple, and primary attacks are often accompanied by fever. On the other hand, lymphogranuloma venereum is caused by C. trachomatis, syphilis by T. pallidum, and granuloma inguinale by K. granulomatis, all of which result in painless genital ulcers.

Understanding Chancroid: A Painful Tropical Disease

Chancroid is a disease that is commonly found in tropical regions and is caused by a bacterium called Haemophilus ducreyi. This disease is characterized by the development of painful genital ulcers that are often accompanied by painful swelling of the lymph nodes in the groin area. The ulcers themselves are typically easy to identify, as they have a distinct border that is ragged and undermined.

Chancroid is a disease that can be quite painful and uncomfortable for those who are affected by it.

Gonorrhoea is best treated with intramuscular ceftriaxone, and it is crucial to notify and treat sexual partners. All patients with gonorrhoea should undergo a test of cure after 2 weeks.

Understanding Gonorrhoea: Causes, Symptoms, Microbiology, and Management

Gonorrhoea is a sexually transmitted infection caused by the Gram-negative diplococcus Neisseria gonorrhoeae. It can occur on any mucous membrane surface, including the genitourinary tract, rectum, and pharynx. The incubation period of gonorrhoea is typically 2-5 days. Symptoms in males include urethral discharge and dysuria, while females may experience cervicitis leading to vaginal discharge. Rectal and pharyngeal infections are usually asymptomatic.

Immunisation against gonorrhoea is not possible, and reinfection is common due to antigen variation of type IV pili and Opa proteins. Local complications may develop, including urethral strictures, epididymitis, and salpingitis, which can lead to infertility. Disseminated infection may also occur, with gonococcal infection being the most common cause of septic arthritis in young adults.

Management of gonorrhoea involves the use of antibiotics. Ciprofloxacin used to be the treatment of choice, but there is now increased resistance to it. Cephalosporins are now more widely used, with a single dose of IM ceftriaxone 1g being the new first-line treatment. If ceftriaxone is refused, oral cefixime 400mg + oral azithromycin 2g should be used. Disseminated gonococcal infection (DGI) and gonococcal arthritis may also occur, with symptoms including tenosynovitis, migratory polyarthritis, and dermatitis. Later complications include septic arthritis, endocarditis, and perihepatitis.

The recommended initial treatment for early Lyme disease is a 14-21 day regimen of oral doxycycline. For non-disseminated Lyme disease, the first line treatment is a 14-day course of oral doxycycline, making option 2 the correct answer. Amoxicillin may be used if doxycycline is contraindicated, such as during pregnancy. Ceftriaxone is reserved for disseminated disease. Treatment should be initiated based on clinical suspicion, as serology may take several weeks to become positive.

Understanding Lyme Disease

Lyme disease is a bacterial infection caused by Borrelia burgdorferi and is transmitted through tick bites. The early symptoms of Lyme disease include erythema migrans, a characteristic bulls-eye rash that appears at the site of the tick bite. This rash is painless, slowly increases in size, and can be more than 5 cm in diameter. Other early symptoms include headache, lethargy, fever, and joint pain.

If erythema migrans is present, Lyme disease can be diagnosed clinically, and antibiotics should be started immediately. The first-line test for Lyme disease is an enzyme-linked immunosorbent assay (ELISA) to detect antibodies to Borrelia burgdorferi. If the ELISA is negative but Lyme disease is still suspected, it should be repeated 4-6 weeks later. If Lyme disease is suspected in patients who have had symptoms for 12 weeks or more, an immunoblot test should be done.

Tick bites can cause significant anxiety, but routine antibiotic treatment is not recommended by NICE. If the tick is still present, it should be removed using fine-tipped tweezers, and the area should be washed. In cases of suspected or confirmed Lyme disease, doxycycline is the preferred treatment for early disease, while ceftriaxone is used for disseminated disease. A Jarisch-Herxheimer reaction may occur after initiating therapy, which can cause fever, rash, and tachycardia.

In summary, Lyme disease is a bacterial infection transmitted through tick bites. Early symptoms include erythema migrans, headache, lethargy, fever, and joint pain. Diagnosis is made through clinical presentation and ELISA testing, and treatment involves antibiotics. Tick bites do not require routine antibiotic treatment, and ticks should be removed using fine-tipped tweezers.

Giardiasis: A Protozoal Parasite Causing Diarrhoeal Illness

Giardiasis is a diarrhoeal disease caused by the flagellate protozoan Giardia intestinalis (previously known as G. lamblia). It is prevalent in areas with poor sanitation and can cause asymptomatic colonisation or acute or chronic diarrhoeal illness. Travellers to highly endemic areas are at high risk of infection. Ingestion of as few as ten Giardia cysts can cause infection. Diarrhoea is the most common symptom of acute Giardia infection, occurring in 90% of symptomatic subjects. The traditional basis of diagnosis is identification of G. intestinalis trophozoites or cysts in the stool of infected patients via stool ova and parasite examination. Standard treatment consists of antibiotic therapy, and metronidazole is the most commonly prescribed antibiotic for this condition. Giardia infection may occur more commonly in families with X-linked agammaglobulinaemia and in sexually active men who have sex with men (MSM).

Understanding Guillain-Barre Syndrome and Miller Fisher Syndrome

Guillain-Barre syndrome is a condition that affects the peripheral nervous system and is often triggered by an infection, particularly Campylobacter jejuni. The immune-mediated demyelination of the peripheral nervous system occurs due to the cross-reaction of antibodies with gangliosides. Studies have shown a correlation between the clinical features of the syndrome and the presence of anti-ganglioside antibodies, particularly anti-GM1 antibodies, which are present in 25% of patients.

Miller Fisher syndrome is a variant of Guillain-Barre syndrome that is characterized by ophthalmoplegia, areflexia, and ataxia. Unlike other forms of Guillain-Barre syndrome, Miller Fisher syndrome usually presents as a descending paralysis, with the eye muscles typically affected first. In 90% of cases, anti-GQ1b antibodies are present.

Understanding the pathogenesis and clinical features of Guillain-Barre syndrome and Miller Fisher syndrome is crucial for accurate diagnosis and effective treatment. Further research is needed to fully understand the mechanisms behind these conditions and to develop more targeted therapies.

Overview of Viral Infections and Their Clinical Manifestations

Hepatitis A, B, and C, leptospirosis, and cytomegalovirus (CMV) are all viral infections that can cause a range of clinical manifestations. Hepatitis A is typically transmitted through ingestion of contaminated food and is most common in resource-poor regions. Leptospirosis is associated with exposure to rodents and contaminated water or soil. Hepatitis B is transmitted through blood and sexual contact, while hepatitis C is most commonly spread through injection drug use. CMV is typically asymptomatic but can cause severe disease in immunocompromised individuals. Understanding the transmission and clinical manifestations of these viral infections is important for accurate diagnosis and appropriate treatment.

Patients who are on long-term steroids or methotrexate and are immunosuppressed should be given VZIG if they are exposed to chickenpox and have no antibodies to varicella. The correct course of action is to conduct antibody testing to determine if the patient is negative, and if so, administer VZIG to protect them from potentially developing a serious chickenpox infection. Although a chickenpox vaccine exists, it is not part of the routine childhood vaccination schedule and is not recommended for immunosuppressed individuals due to its live nature. IV aciclovir can be given for chickenpox infection in immunocompromised individuals, but VZIG is more appropriate as it can help prevent the infection from manifesting. Administering VZIG once the patient has already shown symptoms of chickenpox is too late, as it has no therapeutic benefit at that point. While oral aciclovir can be given prophylactically or to reduce the severity of symptoms, VZIG is more appropriate for immunosuppressed patients who are at high risk of severe chickenpox infection.

Managing Chickenpox Exposure in At-Risk Groups

Chickenpox is usually a mild illness in children with normal immune systems, but it can cause serious systemic disease in at-risk groups. Pregnant women and their developing fetuses are particularly vulnerable. Therefore, it is crucial to know how to manage varicella exposure in these special groups.

To determine who would benefit from active post-exposure prophylaxis, three criteria should be met. Firstly, there must be significant exposure to chickenpox or herpes zoster. Secondly, the patient must have a clinical condition that increases the risk of severe varicella, such as immunosuppression, neonates, or pregnancy. Finally, the patient should have no antibodies to the varicella virus. Ideally, all at-risk exposed patients should have a blood test for varicella antibodies. However, this should not delay post-exposure prophylaxis past seven days after initial contact.

Patients who meet the above criteria should be given varicella-zoster immunoglobulin (VZIG). Managing chickenpox exposure in pregnancy is an important topic that requires more detailed discussion, which is covered in a separate entry in the textbook.

It is recommended to refrain from participating in contact sports for a period of 4 weeks if diagnosed with glandular fever.

Understanding Infectious Mononucleosis

Infectious mononucleosis, also known as glandular fever, is a viral infection caused by the Epstein-Barr virus (EBV) in 90% of cases. It is most commonly seen in adolescents and young adults. The classic triad of symptoms includes sore throat, pyrexia, and lymphadenopathy, which are present in around 98% of patients. Other symptoms include malaise, anorexia, headache, palatal petechiae, splenomegaly, hepatitis, lymphocytosis, haemolytic anaemia, and a maculopapular rash. The symptoms typically resolve after 2-4 weeks.

The diagnosis of infectious mononucleosis is confirmed through a heterophil antibody test (Monospot test) in the second week of the illness. Management is supportive and includes rest, drinking plenty of fluids, avoiding alcohol, and taking simple analgesia for any aches or pains. It is recommended to avoid playing contact sports for 4 weeks after having glandular fever to reduce the risk of splenic rupture.

Interestingly, there is a correlation between EBV and socioeconomic groups. Lower socioeconomic groups have high rates of EBV seropositivity, having frequently acquired EBV in early childhood when the primary infection is often subclinical. However, higher socioeconomic groups show a higher incidence of infectious mononucleosis, as acquiring EBV in adolescence or early adulthood results in symptomatic disease.

Common Viruses that Cause Gastroenteritis

Gastroenteritis is a self-limiting illness caused by several viruses, including rotavirus, enteric adenovirus, small round-structured virus (SRSV), norovirus, and astrovirus. Among these, rotavirus is the most common cause of gastroenteritis in children under 5 years of age, while norovirus affects people of all ages. Rotavirus causes infant deaths worldwide, but acquired immunity develops after one episode. Norovirus is usually transmitted through contaminated food or water, while adenovirus is endemic throughout the year and commonly affects children in daycare settings. SRSV is another name for norovirus, and astrovirus is associated with contaminated food and water. Symptoms of gastroenteritis include anorexia, low-grade fever, vomiting, and watery diarrhea, but most cases do not require medication and can be managed with supportive treatment. Death from dehydration remains common in developing countries.

Campylobacter jejuni is a prevalent cause of bacterial food poisoning in the UK, typically transmitted through contaminated food or drink. Symptoms usually appear 2-5 days after exposure and may include abdominal cramps, diarrhea (which may or may not be bloody), nausea, vomiting, and fever. While symptoms are usually mild and self-limiting, severe cases or immunocompromised patients may require antibiotic treatment. Bacillus cereus and Clostridium perfringens are less likely causes of food poisoning due to their short incubation periods and milder symptoms. Rotavirus is a common cause of viral gastroenteritis in children, but adults are rarely affected due to immunity. Staphylococcus aureus can also cause food poisoning, with symptoms appearing 2-6 hours after ingestion and including nausea, vomiting, and abdominal pain.

A man with a 5-year history of HIV is on antiretroviral treatment with atazanavir, emtricitabine, and tenofovir. The aim of this treatment is to reduce viral load (< 50 copies/ml), improve CD4 count (above 350 cells/mm3), reduce transmission, and increase quality of life without unacceptable drug side-effects. During routine check-ups, the patient's CD4 count, HIV viral RNA load, renal and hepatic function, cholesterol, blood sugar, triglycerides, and lactate are assessed. The target level for this patient's CD4 count is above 350 cells/mm3. A CD4 count below 200 cells/mm3 greatly exposes the patient to opportunistic infections. Antiretroviral treatment usually involves a combination of at least three drugs classified as nucleoside reverse transcriptase inhibitors (NRTIs), non-nucleoside reverse transcriptase inhibitors (NNRTIs), protease inhibitors (PIs), or 'others'. These drugs may have side-effects such as lipoatrophy, hepatotoxicity, lipodystrophy syndrome, lactic acidosis, Steven-Johnson syndrome, drug-drug interactions, hyperbilirubinemia, peripheral neuropathy, bone marrow suppression, anaemia, pancreatitis, and insulin resistance/hyperglycaemia.

Diagnostic Tests for Lyme Disease: Understanding the Results

Lyme disease is a common illness caused by the spirochaete B. burgdorferi, transmitted to humans via tick bites. Serologic testing is the most frequently used diagnostic tool, but false positives and negatives are common. The enzyme immunoassay (EIA) or enzyme-linked immunosorbent assay (ELISA) is the first step, followed by a western blot if necessary. However, serologic results cannot distinguish active from inactive disease. Antinuclear antibodies and rheumatoid factor test results are negative in B. burgdorferi infection. The erythrocyte sedimentation rate is usually elevated but is not specific to detect infection. Culture of joint fluids can rule out gout and pseudogout, but detection of B. burgdorferi DNA in synovial fluid is not reliable. Blood cultures are impractical. Understanding the limitations of these tests is crucial for accurate diagnosis and treatment of Lyme disease.

Management of Asymptomatic Bacteriuria

Asymptomatic bacteriuria is a common finding in clinical practice, but it does not require antibiotic treatment. Patients with asymptomatic bacteriuria are at increased risk for symptomatic UTI, but treatment does not decrease the frequency of symptomatic UTIs nor improve other outcomes. Therefore, screening for or treatment of asymptomatic bacteriuria is not appropriate and should be discouraged.

Treatment of asymptomatic bacteriuria in women should be reserved for pregnant patients, those undergoing a urological procedure that may produce mucosal bleeding, and the significantly immunosuppressed. Pregnant patients are considered immunosuppressed UTI hosts due to the physiological changes associated with pregnancy, which increase the risk for serious complications even in healthy pregnant women. However, it should not be treated in diabetic patients, elderly individuals, or those with indwelling catheters.

Antibiotic treatment is not recommended in this clinical scenario, even in symptomatic UTIs. Current UK antimicrobial guidance recommends treatment for 3-7 days, depending on the clinical case, not with a single-dose administration. Investigating the renal tract is also not necessary for a single finding of asymptomatic bacteriuria.

Intravenous antibiotic treatment is reserved for complicated UTIs, in which case the patient would present far more unwell than what is seen in this scenario. Underlying conditions that predispose patients to complicated UTIs include diabetes, renal failure, functional or anatomic abnormality of the urinary tract, renal transplantation, an indwelling catheter stent, or immunosuppression.

The CD4 count is a reliable way to measure the immune system’s response to HIV infection. In HIV-negative individuals, the CD4 count is usually maintained above 600-800 cells/µl. However, without antiretroviral therapy, HIV-positive individuals will experience a gradual decline in CD4 count over time. A CD4 count of less than 350 cells/µl increases the risk of opportunistic infections, while a count of less than 200 cells/µl indicates an 80% risk of developing an OI within three years. Some patients may remain well despite having a low CD4 count, depending on viral load and host immunity factors. Different OIs are more likely at different CD4 counts. The World Health Organization now recommends starting ART in every HIV-positive individual, regardless of CD4 count.

A CXR is usually normal in HIV-positive individuals without chronic respiratory disorders. Blood cultures may help diagnose an OI, but do not estimate the risk of developing OIs. HIV-positive individuals often have an abnormal FBC, but this does not help with risk assessment for OIs. TST is used to check for immunity to TB and diagnose LTBI. HIV-positive individuals are at higher risk of TB disease, but may have a muted response to TST due to their compromised immunity. TST can be useful in assessing eligibility for isoniazid preventive therapy, but not in assessing disease stage and risk of OIs in general.

To determine if a patient still has the hepatitis C virus, a HCV PCR test is necessary as only a small percentage of patients naturally clear the infection. Unfortunately, there is currently no vaccine available for hepatitis C.

When interpreting hepatitis B serology, the presence of surface antigen (HBsAg) typically indicates acute disease and triggers the production of anti-HBs. If HBsAg is present for more than six months, it suggests chronic disease and is infectious. Anti-HBs indicates immunity from either exposure or vaccination, while anti-HBc suggests previous or current infection. The appearance of IgM anti-HBc during acute or recent hepatitis B infection lasts for about six months. HbeAg is a marker of infectivity as it results from the breakdown of core antigen from infected liver cells.

Understanding Hepatitis C: Transmission, Complications, and Management

Hepatitis C is a viral infection that is expected to become a significant public health concern in the UK in the coming years. It is estimated that around 200,000 people in the country are chronically infected with the virus, with intravenous drug users and those who received blood transfusions prior to 1991 being at higher risk. The virus is an RNA flavivirus with an incubation period of 6-9 weeks.

Transmission of the virus can occur through needle stick injuries, vertical transmission from mother to child (especially if coexistent with HIV), and sexual intercourse (although the risk is low). There is currently no vaccine for hepatitis C. Symptoms of acute infection include a transient rise in serum aminotransferases, jaundice, fatigue, and arthralgia.

Around 15-45% of patients will clear the virus after an acute infection, while the majority (55-85%) will develop chronic hepatitis C. This can lead to complications such as rheumatological problems, cirrhosis, hepatocellular cancer, and cryoglobulinemia. Treatment for chronic infection depends on the viral genotype and aims for sustained virological response (SVR), defined as undetectable serum HCV RNA six months after the end of therapy. Interferon-based treatments are no longer recommended, with protease inhibitors such as daclatasvir and sofosbuvir or sofosbuvir and simeprevir being used instead. However, these treatments can have side effects such as haemolytic anaemia, cough, flu-like symptoms, depression, and fatigue.

In conclusion, understanding the transmission, complications, and management of hepatitis C is crucial in addressing this growing public health concern.